Warfarin

Warfarin is an oral anticoagulant that prevents blood clots by inhibiting vitamin K–dependent clotting factor synthesis.

Structure of Warfarin

  • Warfarin is a synthetic coumarin derivative with a 4-hydroxycoumarin core structure substituted with a 3-phenylpropyl side chain.
  • Chemical Formula: C₁₉H₁₆O₄
Advertisements

Structure of Warfarin

Mode of Action

  • Vitamin K Epoxide Reductase Inhibition: Blocks the enzyme vitamin K epoxide reductase, preventing the regeneration of reduced vitamin K.
  • Coagulation Factor Inhibition: Reduces the synthesis of vitamin K-dependent clotting factors II, VII, IX, and X.
  • Anticoagulant Effect: Prolongs clotting times (INR) to prevent thrombosis and embolism.
Advertisements

Uses

  • Prophylaxis and Treatment of Thromboembolic Disorders: Prevents deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke.
  • Atrial Fibrillation: Reduces the risk of stroke by preventing clot formation.
  • Mechanical Heart Valves: Prevents thrombus formation on artificial valves.
  • Myocardial Infarction: Lowers the risk of recurrent heart attacks by preventing clot formation.

Structure-Activity Relationship (SAR)

  • Coumarin Core: Essential for binding to vitamin K epoxide reductase.
  • 3-Phenylpropyl Side Chain: Enhances binding affinity and specificity for the target enzyme.
  • Hydroxyl Group: Increases solubility and facilitates hydrogen bonding with the enzyme.
  • Substituents: Modifications on the phenyl ring can affect potency, metabolism, and duration of action.
Advertisements

Synthesis of Warfarin

synthesis of Warfarin

Thank you for reading from Firsthope's notes, don't forget to check YouTube videos!

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.